Click Therapeutics develops prescription digital therapeutics (regulated software-as-medical-treatment mobile applications) that deliver therapeutic interventions and integrate with pharmacotherapy, supported by clinical trials and regulatory submissions.
Published Aug 15, 2026
| Starting Price | Not publicly standardized; depends on prescription channel and coverage; some users report prescription/cost friction | Not publicly standardized; distribution via prescription, payers, and employer routes | Historically faced reimbursement challenges; business stability concerns reported |
| Best For | Organizations seeking a vendor that develops regulated digital therapeutics and conducts randomized trials across multiple indications | Organizations seeking digital CBT-style treatments for anxiety and insomnia with existing regulatory clearances | Reference point for regulatory pathways; historical commercialization challenges useful for risk analysis |
| Key Strengths | Documented clinical development programs and partnerships with pharmaceutical companies; emphasis on regulatory submissions and clinical trials | Focused consumer-style productization for mental health with regulatory clearances in specific indications | Early experience with regulatory pathways and product commercialization; historical lessons on reimbursement risk |
| Key Weaknesses | User-reported friction around prescription access and finite program access periods; limited public detail on enterprise security certifications | Vendor-published metrics should be independently validated; coverage and reimbursement remain considerations | Business model and reimbursement history demonstrate category-level commercialization risk |
—